Whether the relatively high proportion of CD33+ myeloid cells observed may reflect a biologically relevant parallel to the myeloid-rich tumor microenvironment commonly seen in HNSCC is unclear, yet possible. This evidence concerns the gene CD33 and head and neck squamous cell carcinoma.